The Baseline Test analyzes over 50 biomarkers in order to empower you to gain an accurate picture of your current state of health
Standard clinical guidelines generally consider GLP-1 weight loss therapy for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as type 2 diabetes, hypertension, or dyslipidemia
However, semaglutide has proven cardiovascular benefit (SELECT), 7+ years of safety data, oral formulation options, and established availability
PCSK9 stimulates Syk, PKC, and NF-B, leading to atherosclerosis progression independently of LDL receptor
To evaluate chronic heroin dependence, anxiety and depression tests were conducted on days 9 and 10